TERTIARY LYMPHOID STRUCTURES AS MARKERS OF ANTI-TUMOR IMMUNITY WITH INDEPENDENT PROGNOSTIC VALUE IN THE PORTEC-3 TRIAL OF HIGH-RISK ENDOMETRIAL CANCER

被引：0
|
作者：
Horeweg, N. [1 ]
Workel, H. [2 ]
Loiero, D. [3 ]
Church, D. [4 ]
Vermij, L. [5 ]
Leon-Castillo, A. [5 ]
De Boer, S. [1 ]
Nout, R. [1 ,6 ]
Powell, M. [7 ]
Mileshkin, L. [8 ]
Mackay, H. [9 ]
Leary, A. [10 ]
Singh, N. [11 ]
Jurgenliemk-Schulz, I. [12 ]
Creutzberg, C. L. [1 ]
Kolzer, V. [3 ,13 ,14 ]
Nijman, H. W. [2 ]
Bosse, T. [15 ]
De Bruyn, M. [2 ]
机构：
[1] Leiden Univ Med Ctr LUMC, Dept Radiat Oncol, Leiden, Netherlands
[2] Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Gynaecol Oncol, Groningen, Netherlands
[3] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland
[4] Wellcome Trust Ctr Human Genet, London, England
[5] Leiden Univ Med Ctr LUMC, Dept Pathol, Leiden, Netherlands
[6] Erasmus MC Canc Inst, Dept Radiotherapy, Rotterdam, Netherlands
[7] Barts Hlth NHS Trust, Dept Clin Oncol, London, England
[8] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[9] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Med Oncol & Haematol, Toronto, ON, Canada
[10] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[11] Barts Hlth NHS Trust, Dept Pathol, London, England
[12] UMC Utrecht, Dept Radiat Oncol, Utrecht, Netherlands
[13] Univ Oxford, Dept Oncol, Oxford, England
[14] Nuffield Dept Med, Oxford, England
[15] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
482
引用
收藏
页码：A99 / A101
页数：3
相关论文
共 36 条
  • [21] Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Kitchener, Henry C.
    Nijman, Hans W.
    Kruitwagen, Roy F.
    Nout, Remi A.
    Verhoeven-Adema, Karen W.
    Smit, Vincent T.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2016, 17 (08): : 1114 - 1126
  • [22] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Carinelli, Silvestro
    Provencher, Diane
    Hanzen, Chantal
    Lutgens, Ludy C. H. W.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    D'Amico, Romerai
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2018, 19 (03): : 295 - 309
  • [23] Adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer: Toxicity and quality-of-life results of the randomized PORTEC-3 trial.
    Creutzberg, Carien L.
    de Boer, Stephanie M.
    Putter, Hein
    Powell, Melanie
    Mileshkin, Linda R.
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ledermann, Jonathan A.
    Ottevanger, P. B.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony W.
    Baron, Marie-Helene
    Nijman, Hans W.
    Nout, Remi A.
    Smit, Vincent T. H. B. M.
    Verhoeven-Adema, Karen
    Kruitwagen, Roy F. P. M.
    Kitchener, Henry C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Safety and Anti-tumor Effects of Docetaxel Plus Cisplatin in Intermediate- and High-risk Endometrial Cancer
    Miyahara, Daisuke
    Katsuta, Takahiro
    Maehara, Miyako
    Takahashi, Yoko
    Fukagawa, Satoshi
    Miyata, Kouhei
    Kiyoshima, Chihiro
    Yotsumoto, Fusanori
    Anan, Haruchika
    Miyamoto, Shingo
    ANTICANCER RESEARCH, 2016, 36 (07) : 3725 - 3729
  • [25] Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
    Post, Cathalijne C. B.
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Nelleke P. B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    D'Amico, Romerai
    Fyles, Anthony
    Baron, Marie Helene
    Kitchener, Henry C.
    Nijman, Hans W.
    Lutgens, Ludy C. H. W.
    Brooks, Susan
    Jurgenliemk-Schulz, Ina M.
    Feeney, Amanda
    Goss, Geraldine
    Fossati, Roldano
    Ghatage, Prafull
    Leary, Alexandra
    Do, Viet
    Lissoni, Andrea A.
    McCormack, Mary
    Nout, Remi A.
    Verhoeven-Adema, Karen W.
    Smit, Vincent T. H. B. M.
    Putter, Hein
    Creutzberg, Carien L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (04): : 975 - 986
  • [26] Induction of Tertiary Lymphoid Structures in Non-Small Cell Lung Cancer Improves B and T Cell Anti-Tumor Immunity
    Kim, H. Mi
    Liu, D.
    Ruffin, A.
    McDonough, A.
    Lampenfeld, C.
    Kunning, S.
    Somasundaram, A.
    Stabile, L.
    Bruno, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E24 - E25
  • [27] Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
    Overacre-Delgoffe, Abigail E.
    Bumgarner, Hannah J.
    Cillo, Anthony R.
    Burr, Ansen H. P.
    Tometich, Justin T.
    Bhattacharjee, Amrita
    Bruno, Tullia C.
    Vignali, Dario A. A.
    Hand, Timothy W.
    IMMUNITY, 2021, 54 (12) : 2812 - +
  • [28] INDUCTION OF TERTIARY LYMPHOID STRUCTURES IN NON-SMALL CELL LUNG CANCER IMPROVES B AND T CELL ANTI-TUMOR IMMUNITY
    Kim, Hye Mi
    Liu, Dongyan
    Ruffin, Ayana
    McDonough, Alexandra
    Lampenfeld, Caleb
    Kunning, Sheryl
    Somasundaram, Ashwin
    Stabile, Laura
    Bruno, Tullia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1180 - A1180
  • [29] Tertiary lymphoid structures restrain cancer evolution by supporting stemlike CD8+T cells for sustained anti-tumor immunity
    Wang, Pengxiang
    Zhou, Chi
    Wei, Zhiting
    Wang, Yue
    Gao, Yuli
    Meng, Fangliangzi
    Zhou, Jian
    Fan, Jia
    Liu, Qi
    Sun, Yunfan
    CANCER RESEARCH, 2024, 84 (06)
  • [30] AGE, HISTOLOGY AND STAGE PREDICT SURVIVAL FOLLOWING ADJUVANT CHEMOTHERAPY AND RADIATION VERSUS RADIATION ALONE IN HIGH-RISK ENDOMETRIAL CANCER: A STUDY BASED ON PORTEC-3 CRITERIA
    Casablanca, Y.
    Tian, C.
    Powell, M.
    Winterhoff, B.
    Chan, J. K.
    Shriver, C. D.
    Hamilton, C. A.
    Maxwell, G. L.
    Darcy, K. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A28 - A29
1234